Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dolly Aguilera

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Neuro-Oncology|May 31, 2007
Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell linesChandra M Das, Dolly Aguilera, Hernan Vasquez, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2010
Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell linesChandra M Das, Peter E Zage, Pete Taylor, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimusDolly Aguilera, Robert Flamini, Claire Mazewski, et al.
Pediatric Blood & Cancer|November 19, 2015
Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with VemurafenibDolly Aguilera, Anna Janss, Claire Mazewski, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 9, 2013
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experienceDolly Aguilera, Claire Mazewski, Jason Fangusaro, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case ReportShubin W Shahab, Prabhumallikarjun Patil, Jason R Fangusaro, et al.
Pediatric Blood & Cancer|May 9, 2023
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumorsThomas Cash, Hunter C Jonus, Maya Tsvetkova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated MedulloblastomaKenneth J Cohen, Vasu Munjapara, Dolly Aguilera, et al.
JCI Insight|December 11, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patientsRobert C Castellino, Hope L Mumme, Andrea T Franson, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Neuro-Oncology|May 31, 2007
Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell linesChandra M Das, Dolly Aguilera, Hernan Vasquez, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2010
Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell linesChandra M Das, Peter E Zage, Pete Taylor, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimusDolly Aguilera, Robert Flamini, Claire Mazewski, et al.
Pediatric Blood & Cancer|November 19, 2015
Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with VemurafenibDolly Aguilera, Anna Janss, Claire Mazewski, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 9, 2013
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experienceDolly Aguilera, Claire Mazewski, Jason Fangusaro, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case ReportShubin W Shahab, Prabhumallikarjun Patil, Jason R Fangusaro, et al.
Pediatric Blood & Cancer|May 9, 2023
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumorsThomas Cash, Hunter C Jonus, Maya Tsvetkova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated MedulloblastomaKenneth J Cohen, Vasu Munjapara, Dolly Aguilera, et al.
JCI Insight|December 11, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patientsRobert C Castellino, Hope L Mumme, Andrea T Franson, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Pageof 3